These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23047386)

  • 1. The value of endoscopic ultrasonography in defining longitudinal gross target volumes for esophageal squamous carcinoma.
    Qiu GQ; Du XH; Yu JP; Zheng YD; Luo HJ; Xu YP; Chen JX; Sun XJ; Ji YL; Tao YL
    Surg Laparosc Endosc Percutan Tech; 2012 Oct; 22(5):424-8. PubMed ID: 23047386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma.
    Konski A; Doss M; Milestone B; Haluszka O; Hanlon A; Freedman G; Adler L
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1123-8. PubMed ID: 15752892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gradient-based delineation of the primary GTV on FLT PET in squamous cell cancer of the thoracic esophagus and impact on radiotherapy planning.
    Zhang G; Han D; Ma C; Lu J; Sun T; Liu T; Zhu J; Zhou J; Yin Y
    Radiat Oncol; 2015 Jan; 10():11. PubMed ID: 25572431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer.
    Yu W; Fu XL; Zhang YJ; Xiang JQ; Shen L; Jiang GL; Chang JY
    Radiother Oncol; 2009 Dec; 93(3):441-6. PubMed ID: 19682760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exploration of the classification of gross tumor volume and pathological staging of esophageal carcinoma].
    Xu Q; Zhu SC; Liu ZK; Cao YK; Song CL; Li YM; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):432-5. PubMed ID: 20819484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography.
    Takizawa K; Matsuda T; Kozu T; Eguchi T; Kato H; Nakanishi Y; Hijikata A; Saito D
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1687-91. PubMed ID: 19788609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endoscopic ultrasound (EUS) in planning radiotherapy target volumes for oesophageal cancer.
    Thomas E; Crellin A; Harris K; Swift S; Montefiore DS
    Radiother Oncol; 2004 Nov; 73(2):149-51. PubMed ID: 15542161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship of gross tumor volume with lymph node metastasis and prognosis of esophageal carcinoma].
    Xu Q; Liu ZK; Cao YK; Li YM; Zhu SC
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):684-7. PubMed ID: 23159082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
    Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma.
    Hou DL; Shi GF; Gao XS; Asaumi J; Li XY; Liu H; Yao C; Chang JY
    Radiat Oncol; 2013 Jul; 8():169. PubMed ID: 23829638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers.
    Machiels M; van Hooft J; Jin P; van Berge Henegouwen MI; van Laarhoven HM; Alderliesten T; Hulshof MC
    Gastrointest Endosc; 2015 Oct; 82(4):641-9. PubMed ID: 25957478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
    Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1385-92. PubMed ID: 15817341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study.
    Tan J; Lim Joon D; Fitt G; Wada M; Lim Joon M; Mercuri A; Marr M; Chao M; Khoo V
    J Med Imaging Radiat Oncol; 2010 Dec; 54(6):562-8. PubMed ID: 21199435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma].
    Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petenief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Hourry S; Talbot JN
    Cancer Radiother; 2005 May; 9(3):152-60. PubMed ID: 16023043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer.
    Lee TH; Ryoo HG; Lee R; Paeng JC; Chung H; Kim HJ
    Medicine (Baltimore); 2021 Jun; 100(24):e26338. PubMed ID: 34128879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ultrasound: impact on survival in patients with esophageal cancer.
    Schrager JJ; Tarpley JL; Smalley WE; Austin MT; Pearson AS
    Am J Surg; 2005 Nov; 190(5):682-6. PubMed ID: 16226939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
    Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
    Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition.
    Schreurs LM; Busz DM; Paardekooper GM; Beukema JC; Jager PL; Van der Jagt EJ; van Dam GM; Groen H; Plukker JT; Langendijk JA
    Dis Esophagus; 2010 Aug; 23(6):493-501. PubMed ID: 20113320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.